Generic Drugs Take Center Stage

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2002, Volume 26, Issue 12

Reform legislation about generic drugs remains at the forefront of debate as innovator companies poise to challenge FDA proposals regarding patent laws.

Related Content:

Quality SystemsRegulatory WatchGeneric DrugsDosage FormsPharmaceutical Technology-12-02-2002
With New Funding, Orbis Medicines to Develop Oral Macrocycles as Alternative to Biologic Drugs
Using Continuous Processes and Automation to Remove Contamination Risk
Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia